Medical Device News Magazine

XRHealth Receives Patent to Measure Sway & Conduct Fall Risk Assessment in Virtual Reality & Augmented Reality Therapy

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

XRHealth, the leader in extended reality and therapeutic telehealth applications, announces today that they received a patent to measure sway and conduct a fall risk assessment using virtual reality and augmented reality therapy.

According to the CDC, one out of five falls results in serious complications like broken bones or head injury. With the new capability, XRHealth can assess the risk of elderly patients’ likelihood of falling, potentially preventing a debilitating injury.

The patent is entitled “Assessing Postural Sway in Virtual Reality or Augmented Reality.” Sway is measured by using a VR/AR platform to measure positional data from a headset or hand sensors. The positional data then determines the center of mass. When the patient enters the virtual/augmented reality environment, it simulates a situation where the user is unbalanced. The data on position and center of mass is then sent to a server to determine if the person poses a risk for falling.

Three million elderly people are sent to emergency rooms each year to treat injuries from falls and 95% of hip fractures are a result of falls. “When treating elderly patients, the ability to measure sway accurately in an AR/VR therapeutic process can potentially prevent falls that can result in long-term disabilities,” said Eran Orr, CEO of XRHealth. “The advantage of using XR to measure sway is that patients can do this from the comfort of their home, during routine extended reality therapy.”

XRHealth has virtual clinics throughout the United States that treat patients remotely with VR/AR-based therapy while they are examined by a licensed XRHealth therapist. The XRHealth platform combines FDA-registered medical applications with advanced data analytics, providing a comprehensive solution for therapists and patients while collecting and analyzing patient interactions with virtual objects in virtual environments.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”